Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,529,100 | 2,086,200 | 1,171,200 | 2,670,100 | 2,836,400 |
| Depreciation Amortization | 686,900 | 340,400 | 168,900 | 1,081,000 | 872,000 |
| Income taxes - deferred | -44,800 | -57,400 | 53,100 | 91,700 | -39,700 |
| Accounts receivable | -254,000 | -187,200 | -134,000 | -435,600 | -225,800 |
| Other Working Capital | 49,400 | -21,900 | -15,600 | 235,400 | -980,300 |
| Other Operating Activity | 325,700 | 396,300 | 213,500 | 908,400 | 570,100 |
| Operating Cash Flow | $4,292,300 | $2,556,400 | $1,457,100 | $4,551,000 | $3,032,700 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -544,700 | -381,500 | -194,700 | -867,400 | -636,800 |
| Net Acquisitions | -1,775,400 | -1,362,900 | -600,000 | -1,200,000 | -900,000 |
| Purchase Of Investment | -6,093,800 | -4,774,300 | -1,919,200 | -5,355,200 | -4,093,900 |
| Sale Of Investment | 7,994,700 | 6,802,700 | 4,068,900 | 5,565,900 | 4,472,600 |
| Purchase Sale Intangibles | -3,000 | -88,000 | -10,000 | -1,095,400 | -1,030,400 |
| Other Investing Activity | -1,800 | -85,900 | -8,400 | -1,106,400 | -1,035,500 |
| Investing Cash Flow | $-421,000 | $198,100 | $1,346,600 | $-2,963,100 | $-2,193,600 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,200 | N/A | N/A | -560,900 | -3,200 |
| Common Stock Issued | -6,700 | -14,300 | -21,200 | N/A | -10,700 |
| Common Stock Repurchased | -3,000,000 | -3,000,000 | -250,000 | -1,365,400 | -1,365,400 |
| Other Financing Activity | -25,100 | -45,800 | 2,600 | -453,700 | -292,600 |
| Financing Cash Flow | $-3,035,000 | $-3,060,100 | $-268,600 | $-2,380,000 | $-1,671,900 |
| Exchange Rate Effect | -23,400 | -18,000 | -900 | 39,400 | 54,400 |
| Beginning Cash Position | 1,573,800 | 1,573,800 | 1,573,800 | 2,326,500 | 2,326,500 |
| End Cash Position | 2,386,700 | 1,250,200 | 4,108,000 | 1,573,800 | 1,548,100 |
| Net Cash Flow | $812,900 | $-323,600 | $2,534,200 | $-752,700 | $-778,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,292,300 | 2,556,400 | 1,457,100 | 4,551,000 | 3,032,700 |
| Capital Expenditure | -544,700 | -381,500 | -194,700 | -867,400 | -636,800 |
| Free Cash Flow | 3,747,600 | 2,174,900 | 1,262,400 | 3,683,600 | 2,395,900 |